Guorei Yinuo has been recognized by the Xi'an Municipal Science and Technology Bureau as a new type of R&D institution in Xi'an.

Release time:

2023-12-08 18:32

Keywords:

On December 5, 2023, Xixian New Area Guorui Yinuo Drug Safety Evaluation and Research Co., Ltd. was certified by the Xi'an Science and Technology Bureau as a "New R&D Institution of Xi'an."

2023 Year 12 Moon 05 On [date], Xixian New Area Guorui Yinuo Drug Safety Evaluation and Research Co., Ltd. was certified by the Xi'an Science and Technology Bureau as a "New R&D Institution of Xi'an." A total of [number] entities were certified this time as New R&D Institutions of Xi'an. 6 a company.

A new type of R&D institution primarily refers to an independent legal entity that is strategically positioned around our city’s leading and emerging industries, with the primary mission of transforming scientific and technological achievements. Such institutions feature diversified investment, market-oriented operations, modern management practices, and the capacity for sustainable development. Their main functions include conducting technological research and development, commercializing scientific and technological achievements, and attracting and cultivating high-end talent.

Guo Rui Yi Nuo Yu 2021 Year 07 The drug has been approved by the National Medical Products Administration. GLP (Certification for Good Laboratory Practice in Non-Clinical Drug Studies) fills a gap in our province. GLP The laboratory’s blank slate will establish a convenient, efficient, and reliable technical platform for new drug research and preclinical safety evaluation in Shaanxi Province’s pharmaceutical industry, playing a crucial role in further enhancing Shaanxi Province’s drug R&D capabilities, its independent innovation capacity in the pharmaceutical sector, and the quality of drug research. Guo Rui Yinuo Yu 2022 Year 08 Monthly through the Ministry of Agriculture and Rural Affairs’ veterinary drug program. GLP Certification, at 2023 Year 05 The company has obtained the “Certificate of Compliance with Good Laboratory Practice” from the China National Accreditation Service for Conformity Assessment (CNAS). CNAS GLP ).

Guo Rui Yi Nuo Yu 2021 Year 12 Obtained the National High-Tech Enterprise Certificate this month, Yu 2023 Year 03 The moon was awarded the title of “Promoter” for the integration of the two chains on Qin Chuangyuan. Yu 2023 Year 03 Month via the Xi'an Municipal Bureau of Industry and Information Technology 2022 Shaanxi Province’s Innovative Small and Medium-sized Enterprises of the Year Determine , at 2023 Year 09 Month via the Xi'an Science and Technology Bureau 2022 Xi'an City Engineering Technology Research Center for the Year Determine 。

Guo Rui Yinuo’s building area reaches 6400 Square meters, Phase I investment 3000 Over several hundred thousand yuan, the facility is now equipped with a liquid chromatography-mass spectrometry system, a high-performance liquid chromatograph, a fully automatic chemiluminescence analyzer, an animal blood analyzer, an automated tissue dehydrator, a pathology diagnostic microscopy system, a microscale laboratory balance, an animal oral and nasal inhalation exposure system, and a UV-Vis spectrophotometer, among other instruments. 300 We have a comprehensive suite of instruments and equipment, and have established experimental platforms covering genetic toxicology, reproductive toxicology, analytical testing, and clinical pathology. Our company is dedicated to non-clinical safety evaluation of drugs, offering clients a one-stop service that includes personalized protocol design, drug screening, pharmacodynamic studies, pharmacokinetic studies, safety assessments, and clinical trial sample analysis. We also provide services for safety evaluations of food, health supplements, cosmetics, and medical devices. In addition, our company has set up platforms for the development of disease model animals and the breeding of laboratory animals. We have assembled a stable, experienced, and highly qualified professional team, and have established systems that comply with U.S. standards. FDA 、 OECD And China NMPA Regulatory requirements GLP System.

Feng Feng, Secretary of the Party Leadership Group and Director of the Provincial Drug Administration, along with his delegation, visited Guorui Yinuo to inspect the progress of the safety assessment laboratory’s construction.

[Bringing Talent to the Airport, Leading Development with Intelligence] Zhang Le: A High-Level Talent Emerging from the Lab

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

WhatsApp：8613940397353

Email：hr-xian@grglp.com

Landline：862933656828

Mr. Su：8619991001701

Ms. Li：8615760970681

Guorei Yinuo has been recognized by the Xi'an Municipal Science and Technology Bureau as a new type of R&D institution in Xi'an.

COOKIES

COOKIES

Sorry，当前栏目暂无内容!

Sorry，The current column has no content!